Affordable Access

Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling Project.

Authors
  • Sacks, F M1
  • Tonkin, A M
  • Shepherd, J
  • Braunwald, E
  • Cobbe, S
  • Hawkins, C M
  • Keech, A
  • Packard, C
  • Simes, J
  • Byington, R
  • Furberg, C D
  • 1 Brigham and Women's Hospital, Harvard Medical School Boston, MA 02115, USA. [email protected]
Type
Published Article
Journal
Circulation
Publisher
Ovid Technologies Wolters Kluwer -American Heart Association
Publication Date
Oct 17, 2000
Volume
102
Issue
16
Pages
1893–1900
Identifiers
PMID: 11034935
Source
Medline
License
Unknown

Abstract

Pravastatin treatment is effective in reducing coronary heart disease events in patients with high or low risk factor status and across a wide range of pretreatment lipid concentrations.

Report this publication

Statistics

Seen <100 times